Focused Wealth Management’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-100
| Closed | -$6.26K | – | 322 |
|
|
2023
Q4 | $6.26K | Hold |
100
| – | – | ﹤0.01% | 608 |
|
|
2023
Q3 | $4.54K | Hold |
100
| – | – | ﹤0.01% | 635 |
|
|
2023
Q2 | $5.61K | Hold |
100
| – | – | ﹤0.01% | 614 |
|
|
2023
Q1 | $4.52K | Hold |
100
| – | – | ﹤0.01% | 662 |
|
|
2022
Q4 | $4.07K | Sell |
100
-800
| -89% | -$32.5K | ﹤0.01% | 664 |
|
|
2022
Q3 | $59K | Buy |
900
+800
| +800% | +$52.4K | 0.01% | 252 |
|
|
2022
Q2 | $6K | Hold |
100
| – | – | ﹤0.01% | 553 |
|
|
2022
Q1 | $6K | Hold |
100
| – | – | ﹤0.01% | 594 |
|
|
2021
Q4 | $8K | Hold |
100
| – | – | ﹤0.01% | 590 |
|
|
2021
Q3 | $11K | Hold |
100
| – | – | ﹤0.01% | 553 |
|
|
2021
Q2 | $16K | Hold |
100
| – | – | ﹤0.01% | 516 |
|
|
2021
Q1 | $12K | Hold |
100
| – | – | ﹤0.01% | 528 |
|
|
2020
Q4 | $15K | Sell |
100
-50
| -33% | -$7.5K | ﹤0.01% | 478 |
|
|
2020
Q3 | $13K | Sell |
150
-50
| -25% | -$4.33K | ﹤0.01% | 458 |
|
|
2020
Q2 | $15K | Hold |
200
| – | – | ﹤0.01% | 430 |
|
|
2020
Q1 | $8K | Hold |
200
| – | – | ﹤0.01% | 458 |
|
|
2019
Q4 | $12K | Hold |
200
| – | – | ﹤0.01% | 465 |
|
|
2019
Q3 | $8K | Hold |
200
| – | – | ﹤0.01% | 491 |
|
|
2019
Q2 | $9K | Hold |
200
| – | – | ﹤0.01% | 503 |
|
|
2019
Q1 | $7K | Hold |
200
| – | – | ﹤0.01% | 490 |
|
|
2018
Q4 | $6K | Hold |
200
| – | – | ﹤0.01% | 498 |
|
|
2018
Q3 | $9K | Hold |
200
| – | – | ﹤0.01% | 446 |
|
|
2018
Q2 | $12K | Hold |
200
| – | – | ﹤0.01% | 410 |
|
|
2018
Q1 | $9K | Buy |
+200
| New | +$9K | ﹤0.01% | 472 |
|